We've found
2,348 Renal Impairment / Chronic Kidney Disease
clinical trials
End Stage Renal Disease Clinical Trial
An Effectiveness-Implementation Trial of SPIRIT in ESRD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
End Stage Renal Disease Clinical Trial
An Effectiveness-Implementation Trial of SPIRIT in ESRD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
End Stage Renal Disease Clinical Trial
An Effectiveness-Implementation Trial of SPIRIT in ESRD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
End Stage Renal Disease Clinical Trial
An Effectiveness-Implementation Trial of SPIRIT in ESRD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Other Clinical Trial
Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases, Nephrology / Urology, Pulmonary / Respiratory Diseases Clinical Trial
Home Hospital for Suddenly Ill Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Impairment Clinical Trial
Study of ISIS 681257 in Patients With Renal Impairment Compared to Healthy Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Nephrology / Urology, Other Clinical Trial
Phase 2 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Otolaryngology Clinical Trial
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Otolaryngology Clinical Trial
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Otolaryngology Clinical Trial
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Otolaryngology Clinical Trial
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Otolaryngology Clinical Trial
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
Evaluation of Metoprolol Pharmacokinetics in Patients Receiving Hi Flux Hemodialysis
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Nephrology / Urology, Other Clinical Trial
Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Diseases Clinical Trial
Effects of Prebiotic Supplementation and Exercise on Inflammatory Markers, Vascular Function and Cognition in CKD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Polycystic Kidney, Autosomal Dominant Clinical Trial
A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Polycystic Kidney, Autosomal Dominant Clinical Trial
A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Dialysis Clinical Trial
End-stage Renal Disease (ESRD) Pilot Study
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Oncology Clinical Trial
A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Oncology Clinical Trial
Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Oncology Clinical Trial
Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Unspecified Adult Solid Tumor, Protocol Specific Clinical Trial
An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVENTM in Subjects With Cancer Who Also Have Impaired Renal Function
Status: Enrolling,
Phase
I
Updated: 6/6/2013
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling,
Phase
III
Updated: 3/30/2016
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling,
Phase
III
Updated: 3/30/2016
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling,
Phase
II
Updated: 4/7/2016
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling,
Phase
II
Updated: 4/7/2016
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling,
Phase
II
Updated: 4/7/2016
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling,
Phase
II
Updated: 4/7/2016
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling,
Phase
II
Updated: 4/7/2016
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling,
Phase
II
Updated: 4/7/2016
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
2,348 Renal Impairment / Chronic Kidney Disease
clinical trials
End Stage Renal Disease Clinical Trial
Updated: 12/31/1969
An Effectiveness-Implementation Trial of SPIRIT in ESRD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
End Stage Renal Disease Clinical Trial
Updated: 12/31/1969
An Effectiveness-Implementation Trial of SPIRIT in ESRD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
End Stage Renal Disease Clinical Trial
Updated: 12/31/1969
An Effectiveness-Implementation Trial of SPIRIT in ESRD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
End Stage Renal Disease Clinical Trial
Updated: 12/31/1969
An Effectiveness-Implementation Trial of SPIRIT in ESRD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Anaemia Clinical Trial
Updated: 12/31/1969
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Other Clinical Trial
Updated: 12/31/1969
Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus With Diabetic Nephropathy Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases, Nephrology / Urology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Home Hospital for Suddenly Ill Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Impairment Clinical Trial
Updated: 12/31/1969
Study of ISIS 681257 in Patients With Renal Impairment Compared to Healthy Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Nephrology / Urology, Other Clinical Trial
Updated: 12/31/1969
Phase 2 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Otolaryngology Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Otolaryngology Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Otolaryngology Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Otolaryngology Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Otolaryngology Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Evaluation of Metoprolol Pharmacokinetics in Patients Receiving Hi Flux Hemodialysis
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Nephrology / Urology, Other Clinical Trial
Updated: 12/31/1969
Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Diseases Clinical Trial
Updated: 12/31/1969
Effects of Prebiotic Supplementation and Exercise on Inflammatory Markers, Vascular Function and Cognition in CKD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Polycystic Kidney, Autosomal Dominant Clinical Trial
Updated: 12/31/1969
A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Polycystic Kidney, Autosomal Dominant Clinical Trial
Updated: 12/31/1969
A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
Updated: 12/31/1969
A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Updated: 12/31/1969
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Dialysis Clinical Trial
Updated: 12/31/1969
End-stage Renal Disease (ESRD) Pilot Study
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Oncology Clinical Trial
Updated: 12/31/1969
A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Oncology Clinical Trial
Updated: 12/31/1969
Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Nephrology / Urology, Oncology Clinical Trial
Updated: 12/31/1969
Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Unspecified Adult Solid Tumor, Protocol Specific Clinical Trial
Updated: 6/6/2013
An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVENTM in Subjects With Cancer Who Also Have Impaired Renal Function
Status: Enrolling,
Phase
I
Updated: 6/6/2013
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 7/6/2015
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 7/6/2015
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 7/6/2015
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 7/6/2015
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 7/6/2015
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 7/6/2015
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 7/6/2015
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 7/6/2015
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 7/6/2015
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 7/6/2015
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling,
Phase
III
Updated: 7/6/2015
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Updated: 12/31/1969
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
Updated: 3/30/2016
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling,
Phase
III
Updated: 3/30/2016
Click here to add this to my saved trials
Chronic Kidney Disease, Secondary Hyperparathyroidism Clinical Trial
Updated: 3/30/2016
A Study to Assess the Efficacy and Safety of Cinacalcet in Pediatric Subjects With SHPT and CKD on Dialysis
Status: Enrolling,
Phase
III
Updated: 3/30/2016
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/9/2015
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling,
Phase
III
Updated: 12/9/2015
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
Updated: 4/7/2016
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling,
Phase
II
Updated: 4/7/2016
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
Updated: 4/7/2016
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling,
Phase
II
Updated: 4/7/2016
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
Updated: 4/7/2016
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling,
Phase
II
Updated: 4/7/2016
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
Updated: 4/7/2016
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling,
Phase
II
Updated: 4/7/2016
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
Updated: 4/7/2016
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling,
Phase
II
Updated: 4/7/2016
Click here to add this to my saved trials
Hyperphosphatemia Clinical Trial
Updated: 4/7/2016
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling,
Phase
II
Updated: 4/7/2016
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials